​

​​

1. What are Semaglutide and Tirzepatide?
Semaglutide and Tirzepatide are injectable medications that are used to support weight loss by helping regulate appetite and improve blood sugar control. Both medications belong to the GLP-1 receptor agonist class and work by mimicking hormones in the body to promote feelings of fullness, reduce hunger, and slow gastric emptying.

​

2. How do Semaglutide and Tirzepatide work for weight loss?
These medications help reduce appetite and cravings, leading to fewer calories consumed. By enhancing the body's natural hormone functions, they help patients feel full after smaller meals and experience less intense hunger between meals. This helps promote sustainable weight loss when combined with a healthy diet and regular physical activity.

​

3. Are Semaglutide and Tirzepatide FDA-approved for weight loss?
Yes, both Semaglutide (brand names Ozempic and Wegovy) and Tirzepatide (brand name Mounjaro) have received FDA approval for use in weight loss in adults with obesity or overweight conditions with associated health issues. These medications have shown significant weight loss results in clinical trials and are considered safe when used as part of a comprehensive weight management plan.

​

4. Who is a good candidate for Semaglutide or Tirzepatide?
These medications are typically recommended for individuals with a BMI (body mass index) of 27 or greater, especially if weight-related health conditions like hypertension, type 2 diabetes, or sleep apnea are present. They may also be suitable for people who have not had success with traditional weight loss methods.

​

5. What results can I expect from Semaglutide or Tirzepatide?
Patients can expect gradual and sustained weight loss when combining these medications with a healthy diet and exercise plan. On average, individuals using Semaglutide or Tirzepatide have experienced significant weight loss of 10-20% of their total body weight over a year or more, depending on their starting weight and adherence to the treatment plan.

​

6. Are there any side effects of Semaglutide or Tirzepatide?
Common side effects include nausea, vomiting, diarrhea, and constipation, especially when starting treatment. These side effects typically diminish over time as your body adjusts to the medication. It’s important to work closely with your healthcare provider to manage any side effects and adjust the treatment if necessary.

​

7. How long do I need to take Semaglutide or Tirzepatide?
The duration of treatment depends on your individual goals and progress. Many patients continue taking these medications long-term to maintain weight loss and improve their health, but it’s essential to regularly evaluate your treatment plan with your healthcare provider. Stopping the medication without support can lead to regaining weight.

​

8. How do I take Semaglutide or Tirzepatide?
Both medications are administered as subcutaneous (under the skin) injections. Semaglutide is typically injected once a week, while Tirzepatide is injected once a week as well. Your healthcare provider will guide you on how to properly administer the injection.

​

9. Can I use Semaglutide or Tirzepatide with other weight loss treatments?
It is possible to combine these medications with other weight loss methods, such as dietary changes, exercise, and behavioral therapy. However, it is important to consult with your healthcare provider before combining treatments to ensure safety and effectiveness.

​

10. How do I get started with Semaglutide or Tirzepatide for weight loss?
The first step is scheduling a consultation with a healthcare provider. They will assess your medical history, determine if these medications are appropriate for you, and help you develop a personalized weight loss plan that includes Semaglutide or Tirzepatide, along with lifestyle changes for optimal results.